Systematic analysis of human antibody response to ebolavirus glycoprotein shows high prevalence of neutralizing public clonotypes.

Systematic analysis of human antibody response to ebolavirus glycoprotein shows high prevalence of neutralizing public clonotypes.
复制标题

DOI:
10.1016/j.celrep.2023.112370
复制
发表时间:
2023-04-25
期刊:
影响因子:
8.8
通讯作者:
--
中科院分区:
生物学1区
文献类型:
--
作者:

文献摘要

参考文献

相似文献

Understanding the human antibody response to emerging viral pathogens is key to epidemic preparedness. As the size of the B cell response to a pathogenic-virus-protective antigen is poorly defined, we perform deep paired heavy- and light-chain sequencing in Ebola virus glycoprotein (EBOV-GP)-specific memory B cells, allowing analysis of the ebolavirus-specific antibody repertoire both genetically and functionally. This approach facilitates investigation of the molecular and genetic basis for the evolution of cross-reactive antibodies by elucidating germline-encoded properties of antibodies to EBOV and identification of the overlap between antibodies in the memory B cell and serum repertoire. We identify 73 public clonotypes of EBOV, 20% of which encode antibodies with neutralization activity and capacity to protect mice in vivo. This comprehensive analysis of the public and private antibody repertoire provides insight into the molecular basis of the humoral immune response to EBOV GP, which informs the design of vaccines and improved therapeutics. Chen et al. investigate the complexity of the human antibody response to a single viral protein, the EBOV GP, using paired single-cell sequencing. The study shows an immense diversity in the clonally expanded B cell repertoire and a high prevalence of public clonotypes.
DOI: 10.1016/j.immuni.2018.06.018
发表时间: 2018-08-21
期刊: Immunity
影响因子: 32.4
作者:
Gilchuk P;Kuzmina N;Ilinykh PA;Huang K;Gunn BM;Bryan A;Davidson E;Doranz BJ;Turner HL;Fusco ML;Bramble MS;Hoff NA;Binshtein E;Kose N;Flyak AI;Flinko R;Orlandi C;Carnahan R;Parrish EH;Sevy AM;Bombardi RG;Singh PK;Mukadi P;Muyembe-Tamfum JJ;Ohi MD;Saphire EO;Lewis GK;Alter G;Ward AB;Rimoin AW;Bukreyev A;Crowe JE Jr
通讯作者: Crowe JE Jr
DOI: 10.1136/mp.55.2.98
发表时间: 2002-04-01
期刊: JOURNAL OF CLINICAL PATHOLOGY-MOLECULAR PATHOLOGY
影响因子: --
作者:
Diss, TC;Liu, HX;Isaacson, PG
通讯作者: Isaacson, PG
DOI: 10.1016/j.cell.2015.12.022
发表时间: 2016-01-28
期刊: Cell
影响因子: 64.5
作者:
Flyak AI;Shen X;Murin CD;Turner HL;David JA;Fusco ML;Lampley R;Kose N;Ilinykh PA;Kuzmina N;Branchizio A;King H;Brown L;Bryan C;Davidson E;Doranz BJ;Slaughter JC;Sapparapu G;Klages C;Ksiazek TG;Saphire EO;Ward AB;Bukreyev A;Crowe JE Jr
通讯作者: Crowe JE Jr
DOI: 10.1038/s41564-021-00972-2
发表时间: 2021-10
影响因子: 28.3
作者:
Dong J;Zost SJ;Greaney AJ;Starr TN;Dingens AS;Chen EC;Chen RE;Case JB;Sutton RE;Gilchuk P;Rodriguez J;Armstrong E;Gainza C;Nargi RS;Binshtein E;Xie X;Zhang X;Shi PY;Logue J;Weston S;McGrath ME;Frieman MB;Brady T;Tuffy KM;Bright H;Loo YM;McTamney PM;Esser MT;Carnahan RH;Diamond MS;Bloom JD;Crowe JE Jr
通讯作者: Crowe JE Jr
DOI: 10.3389/fimmu.2021.706757
发表时间: 2021
影响因子: 7.3
作者:
Gilchuk P;Guthals A;Bonissone SR;Shaw JB;Ilinykh PA;Huang K;Bombardi RG;Liang J;Grinyo A;Davidson E;Chen EC;Gunn BM;Alter G;Saphire EO;Doranz BJ;Bukreyev A;Zeitlin L;Castellana N;Crowe JE Jr
通讯作者: Crowe JE Jr